References
- Levy C, Bidet P, Bonacorsi S, Cohen R, Bacterial Meningitis Study Group. Group A streptococcal meningitis in children: French surveillance network from 2001 to 2012. Pediatr Infect Dis J. 2013;32:1041–2.
- de Almeida Torres RS, Fedalto LE, de Almeida Torres RF, Steer AC, Smeesters PR. Group A Streptococcus meningitis in children. Pediatr Infect Dis J. 2013;32:110–4.
- Baraldes MA, Domingo P, Mauri A, Monmany J, Castellanos M, Pericas R, et al. Group A streptococcal meningitis in the antibiotic era. Eur J Clin Microbiol Infect Dis. 1999;18:572–8.
- McMillan DJ, Drèze PA, Vu T, Bessen DE, Guglielmini J, Steer AC, et al. Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study. Clin Microbiol Infect. 2013;19:E222–9.
- Sanderson-Smith M, De Oliveira DM, Guglielmini J, McMillan D, Vu T, Holien J. A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. J Infect Dis. 2014;210(8):1325–38.
- Baroux N, D'Ortenzio E, Amedeo N, Baker C, Ali Alsuwayyid B, Dupont-Rouzeyrol M, et al. The emm-cluster typing system for group A Streptococcus identifies epidemiologic similarities across the Pacific region. Clin Infect Dis. 2014;59(7):e84–9.
- Shulman ST, Tanz RR, Dale JB, Steer AC, Smeesters PR. Added value of the emm-Cluster typing system to analyze group A Streptococcus epidemiology in high-income settings. Clin Infect Dis. 2014;59(11):1651–2.
- Commons RJ, Smeesters PR, Proft T, Fraser JD, Robins-Browne R, Curtis N. Streptococcal superantigens: categorization and clinical associations. Trends Mol Med. 2014;20:48–62.
- Descheemaeker P, Van Loock F, Hauchecorne M, Vandamme P, Goossens H. Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993–1994. J Med Microbiol. 2000;49:467–71.
- Dale JB, Penfound TA, Chiang EY, Walton WJ. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine. 2011;29:8175–8.
- Santos MS, Ribeiro GS, Oliveira TQ, Santos RC, Gouveia E, Salgado K, et al. Burden of group A streptococcal meningitis in Salvator, Brazil:report of 11 years of population based surveillance. Int J infect Dis. 2009;13:456–61.
- Busetti M, Marchetti F, Croci E, L'Erario I, Creti R, D'Agaro P. Group A streptococcal meningitis: a case report. New Microbiol. 2013;36:419–22.
- Van Zitteren LM, Arents NL, Halbertsma F. Group-A-streptococcal meningits in a 7-year-old child a rare pathogen in a non-immune compromised patient. BMJ Case Rep. 2011;
- O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clin Infect Dis. 2007;45:853–62.
- Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, et al. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2009;47:1155–65.
- Lepoutre A, Doloy A, Bidet P, Leblond A, Perrocheau A, Bingen E, et al. Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J Clin Microbiol. 2011;49:4094–100.